Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis have?
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis has 571 citations in the OpenAlex counts PICO Portal stores.
When was Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis published?
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis has 2019 year in the PICO Portal index.
What is the open-access status of Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis?
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis has green oa status in the PICO Portal index.
What is the DOI of Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis?
The DOI for Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis is on the source record.
What is the PMID of Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis?
The PMID for Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis is on the source record.
What is the OpenAlex record for Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis?
The OpenAlex for Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis is on the source record.